<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05098002</url>
  </required_header>
  <id_info>
    <org_study_id>I 1946021</org_study_id>
    <nct_id>NCT05098002</nct_id>
  </id_info>
  <brief_title>Mindfulness Meditation</brief_title>
  <official_title>Mindfulness Meditation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Roswell Park Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Roswell Park Cancer Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To offer Roswell Park patients and caregivers a variety of options to reduce their stress and&#xD;
      improve their psychological well-being amidst the difficulty of cancer&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 29, 2021</start_date>
  <completion_date type="Anticipated">October 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility - Enrollment rates</measure>
    <time_frame>6 weeks</time_frame>
    <description>Number of participants enrolled in virtual classes vs in person classes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Acceptability</measure>
    <time_frame>6 weeks</time_frame>
    <description>Percentage of participants who choose in person classes vs. virtual classess</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Cancer</condition>
  <arm_group>
    <arm_group_label>Mindful based stress classes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>6 week mindfulness program</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mindfulness program</intervention_name>
    <description>6 week class designed to improve psychological well-being</description>
    <arm_group_label>Mindful based stress classes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Being over 18 years old&#xD;
&#xD;
          -  Cancer survivor or a caregiver of cancer patient/survivor.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unwilling or unable to complete the assessment in English.&#xD;
&#xD;
          -  Are unwilling or unable to follow protocol requirements.&#xD;
&#xD;
          -  Have any condition which in the Investigator's opinion deems the subject an unsuitable&#xD;
             candidate to participate in this study including (based on criteria from the&#xD;
             Mindfulness-based stress reduction (MBSR) authorized curriculum guide):&#xD;
&#xD;
               1. Drug addiction (or recent recovery)&#xD;
&#xD;
               2. Bereavement (recent loss)&#xD;
&#xD;
               3. Mental health inpatient (recently discharged)&#xD;
&#xD;
               4. Current depression or other major psychiatric diagnoses (including suicidality or&#xD;
                  suicidal ideation) that would interfere with participation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elizabeth Bouchard, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Roswell Park Comprehensive Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elizabeth Bouchard, MD</last_name>
    <phone>716-845-2300</phone>
    <email>Elizabeth.Bouchard@roswellpark.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Roswell Park Comprehensive Cancer Center</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14263</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Bouchard, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 18, 2021</study_first_submitted>
  <study_first_submitted_qc>October 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 28, 2021</study_first_posted>
  <last_update_submitted>November 1, 2021</last_update_submitted>
  <last_update_submitted_qc>November 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

